Given the role of nNOS described above, this undermines the interpretation of experiments that demonstrate any protective action of CsA and, in the absence of other more specific pharmacological agents, has made it difficult to assign an unambiguous role for mPTP in glutamate toxicity or stroke. The gene discussed is NOS1; the disease is Stroke.